Amyloid Antibodies as Future Treatment for Early Alzheimer’s Disease?

More antibodies targeting amyloid have been developed, and one of the raising questions is if they are usable in treating early Alzheimer’s disease. In this MEDtalk, Consultant Neurologist Kristian Steen Frederiksen presents studies investigating the efficacy and safety of the drug lecanemab.